ChemoMetec A/S : Major shareholder announcement - BlackRock, Inc.
July 04, 2024 at 03:08 pm EDT
Share
Danish
English
Published: 2024-07-04 21:03:00 CEST
ChemoMetec
Major shareholder announcements
Major shareholder announcement - BlackRock, Inc.
4 July 2024
Major shareholder announcement - BlackRock, Inc.
ANNOUNCEMENT NO. 271
Major shareholder announcement - BlackRock, Inc.
Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock Investment Management (UK) Limited on 3 July 2024, increased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to above 10%, and that the holding thus exceeds the 10 per cent limit in section 38 of the Capital Markets Act.
The aggregate holding of shares and voting rights of BlackRock, Inc. in ChemoMetec A/S amounts to 14,21% of the total share capital and voting rights in ChemoMetec A/S.
For further information
CEO Martin Helbo Behrens
Phone: (+45) 4813 1020
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec's instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec's customers include some of the world's leading pharmaceutical companies.
ChemoMetec was founded in 1997 and is listed on the Nasdaq Copenhagen stock exchange. For more information, go towww.chemometec.com
This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page
Attachments
Original Link
Permalink
Disclaimer
ChemoMetec A/S published this content on
04 July 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
04 July 2024 19:07:05 UTC.
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Companyâs activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Companyâs analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.